Academic literature on the topic 'Ruthenium-dmso'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ruthenium-dmso.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ruthenium-dmso"

1

Saadh, Mohamed. "Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3’-dicarboxy-2,2’-bipyridine ligand." Pharmacia 70, no. 3 (2023): 803–7. http://dx.doi.org/10.3897/pharmacia.70.e111508.

Full text
Abstract:
Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3’-dicarboxy-2,2’-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl2(3,3’-dcbpy)(DMSO)2], have been synthesized, characterized, and studied for its anticancer activity against MDA-MB-231 and MRC-5 cell lines, as well as its mechanisms of action and selectivity. According to research, [RuCl2 (3,3’-dcbpy)(DMSO)2], is highly cytotoxic to the MDA-MB-231 and minimum cytotoxic to MR
APA, Harvard, Vancouver, ISO, and other styles
2

Chandra, Manish, D. Shankar Pandey, M. Carmen Puerta та Pedro Valerga. "Ap-cymene-ruthenium(II)–DMSO complex, [(η6-C10H14)RuCl2(DMSO)]". Acta Crystallographica Section E Structure Reports Online 58, № 1 (2001): m28—m29. http://dx.doi.org/10.1107/s1600536801021237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Saadh, Mohamed. "Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3'-dicarboxy-2,2'-bipyridine ligand." Pharmacia 70, no. (3) (2023): 803–7. https://doi.org/10.3897/pharmacia.70.e111508.

Full text
Abstract:
Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3'-dicarboxy-2,2'-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl<sub>2</sub>(3,3'-dcbpy)(DMSO)<sub>2</sub>], have been synthesized, characterized, and studied for its anticancer activity against MDA-MB-231 and MRC-5 cell lines, as well as its mechanisms of action and selectivity. According to research, [RuCl<sub>2</sub> (3,3'-dcbpy)(DMSO)<sub>2</sub>], is highly cytotoxic t
APA, Harvard, Vancouver, ISO, and other styles
4

Zhu, Dengsen, Cong Zhao, Xuesong Wang, Wenji Wang, Baohuai Wang, and Weihong Du. "Roles of DMSO-type ruthenium complexes in disaggregation of prion neuropeptide PrP106–126." RSC Advances 6, no. 19 (2016): 16055–65. http://dx.doi.org/10.1039/c5ra21523d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jaswal, Jaswinder S., Steven J. Rettig, and Brian R. James. "Ruthenium(III) complexes containing dimethylsulfoxide or dimethylsulfide ligands, and a new route to trans-dichlorotetrakis(dimethylsulfoxide)ruthenium(II)." Canadian Journal of Chemistry 68, no. 10 (1990): 1808–17. http://dx.doi.org/10.1139/v90-282.

Full text
Abstract:
The new Ru(III) complex tran-[(dmso)2H]+[RuCl4(dmso)2]− (1) (dmso = S-bonded dimethylsulfoxide) has been synthesized. New synthetic routes are reported for mer-RuX3(dms)3 complexes (dms = dimethylsulfide, X = Cl (2) and Br (3)) and for trans-RuCl2(dmso)4 (4). The complexes have been studied spectroscopically while 1, 2 and 4 have also been characterized crystallographically. Crystals of 1 are monoclinic, P2/n, a = 9.280(3), b = 16.518(4), c = 14.034(3) Å, β = 100.78(2)°, Z = 4, ρc = 1.75 g cm−3. Crystals of 2 are orthorhombic, Pca21a = 10.764(2), b = 11.375(1), c = 12.243(1) Å, Z = 4, ρc = 1.7
APA, Harvard, Vancouver, ISO, and other styles
6

Messori, Luigi, Felix Kratz, and Enzo Alessio. "The Interaction of the Antitumor Complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study." Metal-Based Drugs 3, no. 1 (1996): 1–9. http://dx.doi.org/10.1155/mbd.1996.1.

Full text
Abstract:
The interaction of two antitumor ruthenium(III) complexes,-Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)]- with human serum apotransferrin (apoTf) was investigated through a number of spectroscopic techniques such as UV-Vis absorption, CD and H1 NMR spectroscopy. Interestingly, the hydrolysis profiles of these complexes in a physiological buffer are markedly affected by the presence, in solution, of apoTf suggesting the occurrence of a specific interaction of their respective hydrolysis products with the protein. The formation of stable adducts with apotransferrin has been demonstrat
APA, Harvard, Vancouver, ISO, and other styles
7

Kljun, Jakob, Saša Petriček, Dušan Žigon, Rosana Hudej, Damijan Miklavčič, and Iztok Turel. "Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine." Bioinorganic Chemistry and Applications 2010 (2010): 1–6. http://dx.doi.org/10.1155/2010/183097.

Full text
Abstract:
Novel ruthenium(III) complexes with histamine[RuCl4(dmso-S)(histamineH)]⋅O(1a) and[RuCl4(dmso-S)(histamineH)](1b) have been prepared and characterized by X-ray structure analysis. Their crystal structures are similar and show a protonated amino group on the side chain of the ligand which is not very common for a simple heterocyclic derivative such as histamine. Biological assays to test the cytotoxicity of the compound1bcombined with electroporation were performed to determine its potential for future medical applications in cancer treatment.
APA, Harvard, Vancouver, ISO, and other styles
8

Rachford, Aaron A., Jeffrey L. Petersen, and Jeffrey J. Rack. "Efficient Energy Conversion in Photochromic Ruthenium DMSO Complexes." Inorganic Chemistry 45, no. 15 (2006): 5953–60. http://dx.doi.org/10.1021/ic0603398.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Groot, Broer de, Hilary A. Jenkins, Stephen J. Loeb, and Shannon L. Murphy. "Ruthenium(II) complexes of the thiacyclophane ligands 2,5,8-trithia[9]-o-cyclophane (TT[9]OC) and 5-oxa-2,8-dithia[9]-o-cyclophane (ODT[9]OC). Structures of RuCl2(DMSO)(TT[9]OC) and RuCl2(PPh3)(ODT[9]OC)." Canadian Journal of Chemistry 73, no. 7 (1995): 1102–10. http://dx.doi.org/10.1139/v95-136.

Full text
Abstract:
Ruthenium(II) complexes of the thiacyclophane ligands 2,5,8-trithia[9]-o-cyclophane (TT[9]OC) and 5-oxa-2,8-dithia[9]-o-cyclophane (ODT[9]OC) were synthesized by ligand displacement reactions employing RuCl2(DMSO)4, RuCl2(PPh3)3, and RuHCl(PPh3)3 as starting materials. X-ray crystal structures of two of these complexes, RuCl2(DMSO)(TT[9]OC) and RuCl2(PPh3)(ODT[9]OC), demonstrate how TT[9]OC and ODT[9]OC bind to Ru(II). RuCl2(DMSO)(TT[9]OC) crystallized as the DMSO solvate in the orthorhombic space group Pbca with a = 19.590(5), b = 16.849(4), c = 13.149(4) Å, V = 4340(3) Å3, and Z = 8. The str
APA, Harvard, Vancouver, ISO, and other styles
10

Motswainyana, William M., and Peter A. Ajibade. "Anticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes." Advances in Chemistry 2015 (February 19, 2015): 1–21. http://dx.doi.org/10.1155/2015/859730.

Full text
Abstract:
Ruthenium compounds are highly regarded as potential drug candidates. The compounds offer the potential of reduced toxicity and can be tolerated in vivo. The various oxidation states, different mechanism of action, and the ligand substitution kinetics of ruthenium compounds give them advantages over platinum-based complexes, thereby making them suitable for use in biological applications. Several studies have focused attention on the interaction between active ruthenium complexes and their possible biological targets. In this paper, we review several ruthenium compounds which reportedly posses
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Ruthenium-dmso"

1

Silva, Tiago Breve da. "Ligantes ancilares definindo a estrutura e reatividade de complexos de rutênio em ROMP: estudos teóricos e experimentais." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/75/75135/tde-17112016-130302/.

Full text
Abstract:
A influência da isomeria cis/trans na reatividade de complexos do tipo [RuCl2(DMSO)3(L)], onde L = DMSO (2;4), n-butilamina (1;3) na polimerização via metátese por abertura de anel (ROMP) foi investigada. Os complexos 1 e 2 apresentaram isomeria fac, enquanto que os complexos 3 e 4 foram trans e mer, respectivamente. Os dados cristalográficos sugerem uma conformação fac para o novo complexo 1. Os parâmetros eletrônicos e estéreos dos ligantes, medidos pelos valores de pka e &theta;, respectivamente, foram usados para interpretação dos resultados. Os monômeros cíclicos usados foram norborneno
APA, Harvard, Vancouver, ISO, and other styles
2

VIDAL, ALESSIO. "THE ENDLESS POSSIBILITIES OF RUTHENIUM DMSO PRECURSORS IN MODERN COORDINATION CHEMISTRY: FROM NOVEL METALLACYCLES OF PORPHYRINS TO NEW ROUTES TO HETEROLEPTIC POLYPYRIDYL COMPOUNDS." Doctoral thesis, Università degli Studi di Trieste, 2021. http://hdl.handle.net/11368/2981623.

Full text
Abstract:
La ricerca svolta durante questo dottorato di ricerca. e riportata in questa Tesi è incentrata sulla progettazione, preparazione e caratterizzazione di diversi sistemi porfirinici supramolecolari, sia metallaciclici che polimerici. Il Capitolo 1 contiene un'introduzione generale sul ruolo chiave delle porfirine come building block funzionali e strutturali per l'assemblaggio di strutture supramolecolari discrete, insieme ai principali concetti del metal-mediated assembly. Il Capitolo 2 è incentrato sullo studio della reattività dei due stereoisomeri [cis,cis,cisRuCl2(CO)2(dmso-O)(dmso-S)] e [ci
APA, Harvard, Vancouver, ISO, and other styles
3

Sens, Llorca Cristina. "New mono- and dinuclear ruthenium complexes containing the 3,5-bis(2-pyridyl)pyrazole ligand. Synthesis, characterization and applications." Doctoral thesis, Universitat de Girona, 2005. http://hdl.handle.net/10803/8034.

Full text
Abstract:
Se han sintetizado dos nuevos complejos mononucleares de Ru, con formula [RuCl2(Hbpp)(dmso)2], a partir de la reacción entre [RuCl2(dmso)4] y Hbpp (3,5-bis(2-piridil)pirazola). El hecho que sólo tres de los seis posibles estereoisómeros se obtengan a partir de esta reacción, se ha racionalizado en base a factores estructurales y electrónicos. Estos complejos se han caracterizado de forma estructural, espectroscópica y electroquímica. En acetonitrilo en medio básico, el isómero trans,cis-[RuCl2(Hbpp)(dmso)2] da lugar a procesos de isomerización de enlace de un ligando dmso cuando el Ru(II) se o
APA, Harvard, Vancouver, ISO, and other styles
4

Ferrer, Vall-llosada Íngrid. "Development of new reusable materials based on Ru complexes with catalytic activity for olefin epoxidation and nitrile hydration." Doctoral thesis, Universitat de Girona, 2015. http://hdl.handle.net/10803/322785.

Full text
Abstract:
In this thesis we present the synthesis and characterization of different types of ruthenium complexes containing N-donor ligands together with dmso, Cl and H2O ligands, along with their complete characterization through spectroscopic and electrochemical techniques. The complexes have been evaluated as catalysts for olefin epoxidation and nitrile hydration in homogeneous phase. On the other hand, taking into account the importance and advantages of the heterogeneous catalysis, we have carried out the immobilization of some of these complexes on silica-type supports and we have evaluated their
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Ruthenium-dmso"

1

Gaur, Ruchi, and Lallan Mishra. "Tuning of Ruthenium – DMSO Complexes for Search of New Anticancer Agents." In Ruthenium Chemistry. Jenny Stanford Publishing, 2018. http://dx.doi.org/10.1201/9781315110585-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!